Precision Medicine, far more than just a buzzword, it represents a paradigm shift in healthcare, promising personalized treatments tailored to each individual's unique genetic makeup, environment, and lifestyle.

Traditional approaches to healthcare often adopt a one-size-fits-all mentality, treating patients based on generalized guidelines and population averages. However, we know that no two individuals are exactly alike, and what works for one person may not be effective for another. This is where precision medicine comes in, offering a bespoke approach that takes into account an individual's genetic variations, biomarkers, and other relevant data points.

Despite its immense potential, precision medicine is not without its challenges. Issues such as data privacy, ethical considerations, and accessibility need to be addressed to ensure equitable access to these groundbreaking therapies. Moreover, integrating precision medicine into mainstream healthcare requires collaboration across disciplines, including clinicians, researchers, policymakers, and industry partners.

This webinar covers the basics of Precision medicine from an expert point of view for better understanding and its usages in healthcare. 

About the Speaker

Rajavarman Kittu, worked as an Assistant Manager [Bioinformatics Division] in Illumina 's official channel partner company (Premas Lifescience Pvt Ltd). In premas , he took care of computational infrastructure, training new users,and troubleshooting advanced users. 

He is experienced in genomics, especially the Next Generation Sequencing (NGS) and Omics data analysis (Microarray). He analysed Cancer genomics, Meta-genomics, Personal genomics and Rare disease. His bioinformatics working experience includes  CAP accredited  KDAH hospital,  diagnostics companies like Positive Bioscience and service providers  like Ocimum BioSolutions.

He have exposure to cancer research while working at Cancer Institute, Center for DNA Finger Printing Diagnostics and Jawaharlal Nehru Centre for Advanced Scientific Research.